Disrupting tumour vasculature and recruitment of aPDL1-loaded platelets control tumour metastasis

Cancer metastasis is the leading cause of death in patients, here, the authors show disrupting tumor vasculature could recruit and activate anti-PD-L1 engineered platelet at metastatic tumor sites to block the PD-1/PD-L1 crosstalk and enhance the anticancer immunotherapy.

Guardado en:
Detalles Bibliográficos
Autores principales: Hongjun Li, Zejun Wang, Zhaowei Chen, Tianyuan Ci, Guojun Chen, Di Wen, Ruoxin Li, Jinqiang Wang, Huan Meng, R. Bryan Bell, Zhifeng Gu, Gianpietro Dotti, Zhen Gu
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/608a4349715044a79d78a3f8c89aa2c6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:608a4349715044a79d78a3f8c89aa2c6
record_format dspace
spelling oai:doaj.org-article:608a4349715044a79d78a3f8c89aa2c62021-12-02T16:50:26ZDisrupting tumour vasculature and recruitment of aPDL1-loaded platelets control tumour metastasis10.1038/s41467-021-22674-32041-1723https://doaj.org/article/608a4349715044a79d78a3f8c89aa2c62021-05-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-22674-3https://doaj.org/toc/2041-1723Cancer metastasis is the leading cause of death in patients, here, the authors show disrupting tumor vasculature could recruit and activate anti-PD-L1 engineered platelet at metastatic tumor sites to block the PD-1/PD-L1 crosstalk and enhance the anticancer immunotherapy.Hongjun LiZejun WangZhaowei ChenTianyuan CiGuojun ChenDi WenRuoxin LiJinqiang WangHuan MengR. Bryan BellZhifeng GuGianpietro DottiZhen GuNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Hongjun Li
Zejun Wang
Zhaowei Chen
Tianyuan Ci
Guojun Chen
Di Wen
Ruoxin Li
Jinqiang Wang
Huan Meng
R. Bryan Bell
Zhifeng Gu
Gianpietro Dotti
Zhen Gu
Disrupting tumour vasculature and recruitment of aPDL1-loaded platelets control tumour metastasis
description Cancer metastasis is the leading cause of death in patients, here, the authors show disrupting tumor vasculature could recruit and activate anti-PD-L1 engineered platelet at metastatic tumor sites to block the PD-1/PD-L1 crosstalk and enhance the anticancer immunotherapy.
format article
author Hongjun Li
Zejun Wang
Zhaowei Chen
Tianyuan Ci
Guojun Chen
Di Wen
Ruoxin Li
Jinqiang Wang
Huan Meng
R. Bryan Bell
Zhifeng Gu
Gianpietro Dotti
Zhen Gu
author_facet Hongjun Li
Zejun Wang
Zhaowei Chen
Tianyuan Ci
Guojun Chen
Di Wen
Ruoxin Li
Jinqiang Wang
Huan Meng
R. Bryan Bell
Zhifeng Gu
Gianpietro Dotti
Zhen Gu
author_sort Hongjun Li
title Disrupting tumour vasculature and recruitment of aPDL1-loaded platelets control tumour metastasis
title_short Disrupting tumour vasculature and recruitment of aPDL1-loaded platelets control tumour metastasis
title_full Disrupting tumour vasculature and recruitment of aPDL1-loaded platelets control tumour metastasis
title_fullStr Disrupting tumour vasculature and recruitment of aPDL1-loaded platelets control tumour metastasis
title_full_unstemmed Disrupting tumour vasculature and recruitment of aPDL1-loaded platelets control tumour metastasis
title_sort disrupting tumour vasculature and recruitment of apdl1-loaded platelets control tumour metastasis
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/608a4349715044a79d78a3f8c89aa2c6
work_keys_str_mv AT hongjunli disruptingtumourvasculatureandrecruitmentofapdl1loadedplateletscontroltumourmetastasis
AT zejunwang disruptingtumourvasculatureandrecruitmentofapdl1loadedplateletscontroltumourmetastasis
AT zhaoweichen disruptingtumourvasculatureandrecruitmentofapdl1loadedplateletscontroltumourmetastasis
AT tianyuanci disruptingtumourvasculatureandrecruitmentofapdl1loadedplateletscontroltumourmetastasis
AT guojunchen disruptingtumourvasculatureandrecruitmentofapdl1loadedplateletscontroltumourmetastasis
AT diwen disruptingtumourvasculatureandrecruitmentofapdl1loadedplateletscontroltumourmetastasis
AT ruoxinli disruptingtumourvasculatureandrecruitmentofapdl1loadedplateletscontroltumourmetastasis
AT jinqiangwang disruptingtumourvasculatureandrecruitmentofapdl1loadedplateletscontroltumourmetastasis
AT huanmeng disruptingtumourvasculatureandrecruitmentofapdl1loadedplateletscontroltumourmetastasis
AT rbryanbell disruptingtumourvasculatureandrecruitmentofapdl1loadedplateletscontroltumourmetastasis
AT zhifenggu disruptingtumourvasculatureandrecruitmentofapdl1loadedplateletscontroltumourmetastasis
AT gianpietrodotti disruptingtumourvasculatureandrecruitmentofapdl1loadedplateletscontroltumourmetastasis
AT zhengu disruptingtumourvasculatureandrecruitmentofapdl1loadedplateletscontroltumourmetastasis
_version_ 1718383039997804544